BiotechTube
Home/NeuroVigil/Dr. Philip Low
DP

Dr. Philip Low

Founder, Chairman & CEO

NeuroVigil

Therapeutic Areas

Sleep DisordersAmyotrophic Lateral Sclerosis (ALS)Parkinson's DiseaseAlzheimer's DiseaseNeurological Disorders

NeuroVigil Pipeline

DrugIndicationPhase
iBrain for Sleep DiagnosticsSleep Disorders (e.g., Sleep Apnea)Commercial
iBrain for Neurological MonitoringParkinson's Disease, Alzheimer's DiseaseDevelopment/Commercial
Pharmaceutical R&D Biomarker PlatformCNS Drug DevelopmentDevelopment
Brain-Computer Interface (BCI) for CommunicationALS/ParalysisDevelopment